HoldsUp

Kiran Krishnan

Microbiome Labs

Kiran Krishnan is a researcher in the field of gut health and the microbiome. His published work focuses on the effects of spore-based probiotics, particularly Bacillus strains, prebiotics, and synbiotics on gut microbiota composition and metabolic activity. His research also investigates the use of dietary and nutritional supplements in models of antibiotic-induced dysbiosis and conditions such as inflammatory bowel disease and hepatic encephalopathy.

36 claims checked on air: 1 context 4 contradicted 14 overstated 12 supported 5 unverified

What they said on air

0:02:09contradictedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Falling estrogen levels in women cause a reduction in gut microbial diversity.

"as estrogen levels start to fall and progesterone levels start to fall, but mostly estrogen, you start to see a reduction in microbial diversity within the gut microbiome. And this has been shown across the board with women." (said at 0:02:09)

A systematic review and meta-analysis comparing hypoestrogenic women (postmenopausal or with premature ovarian insufficiency, n=1,267) to euestrogenic premenopausal controls (n=463) found no significant difference in gut microbial alpha-diversity (Shannon index, p=0.990) or major bacterial phyla. While some individual observational studies have reported modest shifts in specific bacterial taxa or non-significant trends, there is no consistent evidence 'across the board' that falling estrogen levels cause a decrease in gut microbial diversity.

0:02:49overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

Studies comparing premenopausal and perimenopausal women show circulating LPS levels are significantly higher in perimenopause.

"In fact, there are studies that look at women in premenopause versus women in perimenopause, and the the amount of circulating LPS is dramatically higher, right?" (said at 0:02:49)

While longitudinal research across the menopausal transition shows evidence of increased gut barrier permeability and microbial translocation, the claim that circulating lipopolysaccharide (LPS) is "dramatically higher" in perimenopausal compared to premenopausal women is overstated. In a longitudinal cohort from the Study of Women's Health Across the Nation (SWAN; n = 65), surrogate markers of microbial translocation and gut permeability increased modestly across the menopause transition (from pre- to postmenopause): LPS-binding protein (LBP) increased by 3.7% (P = 0.05), soluble CD14 (sCD14) by 8.9% (P = 0.0002), and fatty acid binding protein 2 (FABP2) by 22.8% (P = 0.001). Direct measurements of circulating LPS do not show dramatic spikes between premenopause and perimenopause.

0:03:09supportedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Approximately 40% to 50% of the microbes in the human gut are made up of gram-negative bacteria.

"and a lot of people have around 40-50% of the microbes in their gut made up of gram-negative bacteria." (said at 0:03:09)

The human intestinal microbiota is predominantly composed of two major bacterial phyla: Firmicutes (primarily Gram-positive) and Bacteroidetes (Gram-negative), alongside other groups such as Proteobacteria. Depending on individual variation, enterotype, and the analytical technique used (e.g., electron microscopy, classical Gram staining, or 16S rRNA sequencing), Gram-negative bacteria frequently constitute between 30% and 50% (or more) of the microbial community in many individuals.

0:04:00unverifiedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

Butyrate activates AMPK, an energy-balancing enzyme important for fat burning.

"Butyrate is a critical short-chain fatty acid that actually helps manage metabolism. It turns on AMPK, which is an energy balancing hormone, which is really important for fat burning." (said at 0:04:00)

No published record matching the claim was located; this does not prove the claim false.

0:04:30overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

A reduction in gut Lactobacilli and Bifidobacteria species is associated with increased weight and a reduction in basal metabolic rate.

"We also tend to see a reduction in lactobacilli uh and bifidobacteria species as well, which both of those reductions then have a weight effect as well because uh reduction in lacto and bifido is associated with an increase in weight and a and a reduction of basal metabolic rate in people." (said at 0:04:30)

While lower relative abundances of Bifidobacterium species (and certain Lactobacillus species) are frequently observed in individuals with obesity compared to lean individuals, and their metabolites (such as short-chain fatty acids) are involved in host metabolic regulation and thermogenesis in preclinical models, the assertion that a reduction in these bacteria is directly associated with or causes a reduction in basal metabolic rate in humans is overstated. Clinical research directly evaluating resting energy expenditure in relation to gut microbiota composition remains very limited and preliminary, with only recent small trials beginning to explore whether specific probiotic strains can influence resting energy expenditure.

0:04:50overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

Women entering perimenopause experience a significant increase in systemic inflammatory markers including hs-CRP, IL-6, and TNF-alpha.

"so, when you look at systemic inflammation in women entering perimenopause, you see a significant rise in things like hs-CRP, which is a global inflammatory marker, interleukin-6, TNF-alpha." (said at 0:04:50)

While longitudinal cohort studies observe elevations in certain inflammatory markers across the menopausal transition, asserting a uniform, significant rise across hs-CRP, IL-6, and TNF-alpha upon entering perimenopause overstates the findings. In the longitudinal Penn Ovarian Aging Study (PMID: 34589780), log IL-6 levels were significantly higher in late perimenopause compared to premenopause, but increases were nuanced, showed significant interactions with early life adversity, and did not demonstrate a uniform baseline rise across hs-CRP and TNF-alpha. Furthermore, prospective studies examining the menopausal transition (such as PMID: 19126626) demonstrate that changes in systemic inflammatory markers like CRP are strongly mediated by concomitant increases in visceral adiposity rather than being an isolated universal cytokine surge across all these markers.

0:07:15contradictedlowGLP1s & Your Gut in Menopause: What Women Need to Know

Elevated lipopolysaccharide (LPS) can reduce testosterone production in women.

"LPS as LPS increases as that lipopolysaccharide increases, it actually can reduce testosterone production even in women" (said at 0:07:15)

The claim states that elevated lipopolysaccharide (LPS) reduces testosterone production in women, which inverts the observed biological relationship. While chronic endotoxemia suppresses testicular steroidogenesis and lowers testosterone in males, in females LPS exposure stimulates ovarian androgen production. In clinical studies, circulating LPS and endotoxemia markers correlate positively with testosterone levels and hyperandrogenic symptoms in women (such as in polycystic ovary syndrome).

0:07:45supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

Estrogen increases glycogen production in the vaginal canal, which feeds Lactobacilli that produce lactic acid to maintain vaginal pH.

"estrogen acts as a metabolite for microbes in the lining of the vaginal canal that increases something called glycogen production. And that glycogen production feeds the lactobacilli that are in the vaginal canal, which then create lactic acid and maintain a healthy vaginal canal." (said at 0:07:45)

Published gynecologic and microbiological literature well establishes that estrogen stimulates the proliferation and maturation of vaginal epithelial cells and the accumulation of glycogen in the vaginal epithelium. This glycogen serves as a primary substrate that is metabolized by vaginal Lactobacillus species to produce lactic acid, which acidifies the vaginal microenvironment (typically maintaining a pH between 3.8 and 4.5) and protects against pathogenic infections.

0:11:40overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

Lipopolysaccharide (LPS) can cross the blood-brain barrier and activate microglial immune cells, inducing brain inflammation.

"It can enter into almost any tissue, including crossing the blood-brain barrier. So, it does a good job of doing that. When it does cross the blood-brain barrier, it does induce inflammation in the brain. It activates something called microglial cells, which are the immune cells in the brain and central nervous system." (said at 0:11:40)

While lipopolysaccharide (LPS) activates microglial cells and induces neuroinflammation, the speaker's claim that LPS 'does a good job' of crossing the blood-brain barrier (BBB) is overstated. Quantitative pharmacokinetic studies in animal models (such as Banks et al., 2010) show that intact LPS penetrates the BBB only minimally (roughly 0.025% of an intravenous dose enters the CNS). Instead of freely penetrating the brain, circulating LPS primarily triggers neuroinflammation by acting on endothelial cells of the BBB, circumventricular organs, vagal afferents, or by disrupting BBB integrity and promoting peripheral cytokine signaling.

0:12:21overstatedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

Lipopolysaccharide (LPS) interferes with serotonin and dopamine binding in the brain.

"LPS also interferes with serotonin and dopamine binding in the brain, which means that your happy hormone and your hormone that drives motivation and reward centers, that's not working very well." (said at 0:12:21)

The claim overstates preclinical animal findings. In rodent models, systemic administration of lipopolysaccharide (LPS) causes neuroinflammation that alters monoaminergic receptor binding in specific brain regions, but these changes are receptor- and region-specific (for instance, decreasing 5-HT1A binding in the hippocampus while increasing dopamine D2 receptor binding in the nucleus accumbens, with no effect on D1 or 5-HT2A receptors). Generalizing these complex, region-specific rodent changes to a blanket assertion that LPS straightforwardly disrupts serotonin and dopamine receptor binding and function in humans is unsupported by direct clinical evidence.

0:12:35contradictedhighGLP1s & Your Gut in Menopause: What Women Need to Know

In the 9-year Netherlands Study on Anxiety and Depression, serum LPS was the only biomarker associated with 100% of anxiety and depression cases and predicted symptom severity.

"there was a 9-year long study called the Netherlands Study on Anxiety and Depression, where they were looking at a number of biomarkers in people that were suffering from anxiety and depression, and then they followed them for 9 years to look at the best associated biomarkers with the condition. They found only one biomarker was associated with 100% of the cases of anxiety and depression, and the level of that biomarker could predict how severe their anxiety and depression was. And in fact, in that 9-year follow-up, for any individuals who that biomarker went away, anxiety and depression went away as well. And that one biomarker was LPS, with serum LPS levels." (said at 0:12:35)

The claim significantly mischaracterizes the methodology and findings of the Netherlands Study of Depression and Anxiety (NESDA). NESDA did not measure circulating serum LPS (endotoxin) levels as a biomarker. Instead, researchers used LPS in vitro as an ex vivo laboratory reagent to stimulate blood samples and assess immune cell cytokine production capacity (such as IL-6, IL-8, and TNF-alpha). Furthermore, no biomarker in NESDA was associated with 100% of anxiety or depression cases, nor did symptoms resolve in 100% of individuals whose inflammatory markers normalized. The actual published NESDA analyses demonstrated small effect sizes (such as standardized beta coefficients up to ~0.14) connecting basal and LPS-stimulated cytokine production capacity with anxiety and depressive symptom persistence over 9 years, much of which was attenuated after controlling for health and lifestyle factors.

0:13:45unverifiedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

Women between ages 40 and 55 report new-onset musculoskeletal pain at a frequency 10 times higher than men in the same age group.

"women report increase in musculoskeletal pain between the ages of 40 and 55 at a frequency 10 times higher than men do in that same age group, right? Uh new onset of musculoskeletal pain, right?" (said at 0:13:45)

No published record matching the claim that women between ages 40 and 55 report new-onset musculoskeletal pain at a frequency 10 times higher than men in the same age group was located; this does not prove the claim false.

0:14:34contradictedhighGLP1s & Your Gut in Menopause: What Women Need to Know

Lipopolysaccharide (LPS) induces bone inflammation that promotes osteoclast-mediated bone resorption over osteoblast activity, driving osteoporosis.

"LPS also drives inflammation in the bone. Inflammation in the bone changes these uh cells called osteoclastic cells, which build bone into Sorry, osteoblastic cells, which build bone into osteoclastic cells, which actually reabsorb reabsorb bone and and uh makes makes bone weaker. Um so it drives osteoporosis as well, right?" (said at 0:14:34)

While lipopolysaccharide (LPS) and chronic inflammation promote bone resorption by stimulating osteoclast differentiation and suppressing osteoblast-mediated bone formation, osteoblasts do not transform into osteoclasts. Osteoblasts and osteoclasts arise from two completely distinct cell lineages: osteoblasts develop from mesenchymal stem cells (mesenchymal lineage), whereas osteoclasts differentiate from hematopoietic stem cells and monocyte/macrophage precursors (hematopoietic lineage). In LPS-induced inflammatory bone loss, LPS stimulates Toll-like receptor 4 (TLR4) on osteoblasts and immune cells to upregulate inflammatory mediators, prostaglandins, and receptor activator of nuclear factor-kappa B ligand (RANKL), which recruit and differentiate macrophage/monocyte precursors into active osteoclasts rather than transdifferentiating osteoblasts.

0:15:05unverifiedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

Lipopolysaccharide (LPS) interacting with visceral fat swells adipocytes to three to four times their normal volume.

"when LPS interacts with visceral fat in the midsection, it actually swells the fat cells, the adipocytes as we call it, three times three to four times its normal volume, right?" (said at 0:15:05)

No published record matching the claim that lipopolysaccharide (LPS) interacts with visceral fat to swell adipocytes to three to four times their normal volume was located; this does not prove the claim false. While LPS (bacterial endotoxin) is well established to trigger inflammatory signaling and alter lipid metabolism in adipose tissue via Toll-like receptor 4 activation, specific experimental evidence demonstrating that LPS exposure acutely or directly causes a 3- to 4-fold expansion of adipocyte volume is lacking.

0:16:20overstatedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

The American Diabetes Association published a paper stating that the primary insult starting insulin resistance is endotoxins (LPS).

"even they published almost now nine years ago that the primary insult, and this is this is quoted from a paper published by the American Diabetes Association, the primary insult that starts the process of insulin resistance is the presence of endotoxins, which is the LPS." (said at 0:16:20)

A landmark 2007 study published in the journal Diabetes (an official journal of the American Diabetes Association) by Cani et al. demonstrated that continuous subcutaneous infusion of bacterial lipopolysaccharide (LPS) in mice induced low-grade inflammation, weight gain, and hepatic insulin resistance, identifying LPS as a 'triggering factor' for diet-induced metabolic disorders. However, attributing this as an official statement of the American Diabetes Association, or framing preclinical rodent research as conclusive proof that endotoxins are the primary insult initiating insulin resistance in humans, overstates both the nature of the publication (an original animal research paper, not an ADA guideline or consensus statement) and the clinical evidence.

0:17:00unverifiedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

The CardioPrevent Study followed 480 pre-diabetic individuals over 60 months and found serum LPS was the only marker predictive of developing type 2 diabetes with over a 98% confidence.

"there was a large-scale study called the CardioPrevent Study, uh which was like 480 people over 60 months. These were people with that that had pre-diabetes risk, and then they were following these individuals to look at all the different markers and look at what percentage of them ended up developing type 2 diabetes. Um, what they found was again, only one marker was serum LPS levels was predictive it with a over 98% hazard ratio confidence ratio of of being a driver of developing diabetes, right?" (said at 0:17:00)

No published record matching a "CardioPrevent Study" of 480 pre-diabetic individuals followed over 60 months evaluating serum LPS as a predictor of incident type 2 diabetes was located; this does not prove the claim false.

0:17:50overstatedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Approximately 40% of adults experience adult-onset acne.

"Somewhere around 40% of adults start to experience adult onset of acne, right?" (said at 0:17:50)

The claim conflates either the overall prevalence of adult acne in women or the subset of adult acne sufferers whose condition began in adulthood. Epidemiological surveys (such as Poli et al., 2001) found an overall acne prevalence of approximately 41% among adult women aged 25–40, and reported that 41% of those affected had late-onset acne (no history of adolescent acne). Consequently, adult-onset acne occurs in approximately 17% of adult women in survey data (and lower in the general adult population including men), rather than 40% of all adults.

0:24:05unverifiedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

GLP-1 receptor agonists increase proteolytic fermentation in the gut, leading to higher production of ammonia and p-cresol.

"where it it reduces saccharolytic fermentation, but it increases something called proteolytic fermentation. And that proteolytic fermentation unfortunately produces more ammonia, p-cresol, and these very inflammatory compounds." (said at 0:24:05)

No published record matching the claim that GLP-1 receptor agonists reduce saccharolytic fermentation and increase proteolytic fermentation to produce higher levels of ammonia and p-cresol was located; this does not prove the claim false. Existing literature examines how gut microbial metabolites such as p-cresol influence endogenous GLP-1 secretion and intestinal transit, but evidence demonstrating that GLP-1 receptor agonist therapy stimulates proteolytic fermentation or elevates gut ammonia and p-cresol levels is lacking.

0:29:10overstatedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Normal bowel transit time in a beet test is between 24 and 30 hours.

"And what you want to see is, you know, somewhere between like 24 to 30-ish hours, right? Um if you're way before that if you're like 12, 13, 14 hours, then your bowels are moving too fast. And if you're in the 40-plus hour range, your bowels are moving too slow." (said at 0:29:10)

While 24 to 30 hours is within the typical median range for whole-gut transit time in healthy adults, defining the normal reference range so narrowly—and classifying transit over 40 hours as abnormally slow—is overstated. In physiological and clinical studies using radiopaque markers, ingestible sensors, or dye tests, normal whole-gut transit time displays wide inter-individual variability, commonly ranging from 12 to 72 hours (with upper limits of normal often exceeding 70 to 120 hours depending on age, sex, diet, and defecation frequency).

0:34:40supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

Approximately 80% of vagus nerve fibers are afferent (transmitting signals from gut to brain), while only 20% are efferent (transmitting from brain to gut).

"if you look at the nerve um you know, structure of of that of the vagus nerve itself, it's 80% of the nerves are what we call afferent nerves, which means 80% of the information is actually going from the gut to the brain. And only 20% coming from the brain down to the gut" (said at 0:34:40)

Extensive anatomical and physiological literature confirms that the vagus nerve is a mixed nerve predominantly composed of sensory (afferent) fibers. Approximately 80% of vagal nerve fibers transmit sensory signals from visceral organs (including the gastrointestinal tract) to the central nervous system, while approximately 20% are motor/secretory (efferent) fibers transmitting signals from the brain to visceral targets.

0:39:01supportedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

Gut microbes metabolize cortisol into byproducts that alter renal potassium-sodium ratios, increasing fluid retention and raising blood pressure.

"there are microbes in the gut that can actually metabolize cortisol, and the metabolic byproducts of that go to the kidneys, and they shift the the solute and solvent ratios in the kidneys. So, the potassium-sodium ratios, which then increases the amount of water that is going back into circulation. So, then the kidneys actually press more water back into circulation in order to increase blood pressure." (said at 0:39:01)

The speaker accurately describes a recognized pathophysiological mechanism known as the glycyrrhetinic acid-like factor (GALF) pathway. Published biochemical and preclinical evidence demonstrates that certain gut microbiota metabolize endogenous glucocorticoids such as cortisol into steroid byproducts. These microbial metabolites enter the circulation and can act as inhibitors of renal 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). When 11β-HSD2 is inhibited, unmetabolized cortisol binds to and activates renal mineralocorticoid receptors, altering renal electrolyte handling (promoting sodium retention and potassium excretion), which increases water reabsorption into the circulation and elevates blood pressure. Because this mechanism is established primarily through in vitro assays, animal models, and mechanistic reviews, the overall certainty of evidence in clinical populations is very low.

0:40:20supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

Interleukin-6 (IL-6) can directly re-trigger the hypothalamic-pituitary-adrenal (HPA) axis without the presence of an external stressor.

"LPS also increases IL-6, which we mentioned before. But one of the things we didn't mention is that IL-6 can actually re-trigger the HPA axis. Even though you don't have another stimulus" (said at 0:40:20)

Interleukin-6 (IL-6) is an established activator of the hypothalamic-pituitary-adrenal (HPA) axis. Controlled clinical trials administering recombinant human IL-6 to healthy human volunteers have demonstrated that IL-6 alone triggers marked, dose-dependent increases in adrenocorticotropic hormone (ACTH) and cortisol secretion without requiring an external psychological or physical stressor.

0:41:55supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

Certain pathogenic bacteria express virulence factors and increase toxin production in response to host stress hormones like epinephrine, norepinephrine, and cortisol.

"some pathogens have learned that when the host is under stress and they're actually measuring your stress hormones like your epinephrine, norepinephrine, cortisol, and so on. When those stress hormones are elevated, that's when they they express their virulence factors and their toxin production" (said at 0:41:55)

The claim is supported by scientific research in the field of microbial endocrinology. Pathogenic bacteria (such as enterohemorrhagic Escherichia coli and Vibrio cholerae) possess sensor proteins (such as the sensor histidine kinase QseC) that recognize mammalian stress hormones, including epinephrine and norepinephrine. Exposure to these host catecholamine stress hormones directly triggers signaling cascades that increase bacterial growth, motility, expression of virulence factors, and toxin production (such as Shiga toxins stx1 and stx2 in E. coli).

0:44:06overstatedvery lowGLP1s & Your Gut in Menopause: What Women Need to Know

A 2015 paper in Frontiers in Immunology concluded that endotoxemia is the primary cause of morbidity and mortality worldwide.

"and in fact a paper published in 2015 in Frontiers of Immunology concluded the same. They said that stress induced endotoxemia or endotoxemia on its own is the number one cause of morbidity and mortality worldwide." (said at 0:44:06)

The cited 2015 review in Frontiers in Immunology ('Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability') notes that chronic non-communicable diseases (NCDs) are the leading causes of disability and mortality worldwide. The authors present a narrative hypothesis that stress-induced intestinal permeability leading to endotoxin translocation may play a contributory or causal role in the low-grade inflammation associated with these diseases. The review does not conclude or establish that endotoxemia itself is the primary or number one cause of worldwide morbidity and mortality.

0:45:28overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

A published 30-day randomized controlled trial of a spore-based probiotic formula showed a 75% reduction in post-meal endotoxemia/LPS.

"and we published in 2017 the first time a paper has been published on a probiotic that alleviates that LPS endotoxemia. Right? So, we showed in a 30-day study, in a simple randomized controlled trial, 38 30-day study with people who had profound endotoxemia, meaning we were screening people for those that had a huge amount of LPS that leaks through. We were able to show a 75% reduction in that LPS in just that 30-day period." (said at 0:45:28)

A 2017 randomized controlled trial evaluated a 30-day supplementation of a 5-strain Bacillus spore-based probiotic in individuals identified as dietary endotoxemia 'responders' (at least a 5-fold post-meal increase in serum endotoxin). The study found a 42% reduction in postprandial endotoxin/LPS in the probiotic group (alongside a 36% increase in the placebo group), not a 75% direct reduction in LPS levels.

0:47:44overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

In a 30-day trial of a spore-based probiotic formula, participants consuming a 2,000-calorie meal experienced a 60% to 70% drop in postprandial ghrelin levels along with a significant increase in leptin.

"what we saw then, after just 30 days of not adjusting diet, lifestyle, or anything else, just taking the this the spore-based probiotic formula, what we saw was a after we gave them the 2,000 calorie meal, we saw about a 60, 70% drop in the ghrelin, the hunger hormone, and a significant increase in leptin." (said at 0:47:44)

A 30-day randomized pilot trial (McFarlin et al., 2017) evaluated a 5-strain Bacillus spore-based probiotic following a high-calorie/high-fat meal challenge in individuals with postprandial dietary endotoxemia. While the trial did find lower postprandial ghrelin concentrations in the probiotic group compared to placebo (6.8 ± 0.4 vs. 8.3 ± 1.1, P = 0.017), this represents an approximately 18% difference between groups, substantially less than the 60% to 70% reduction claimed.

0:49:06supportedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Normal physiological human gastric pH ranges from 1.2 to 1.3, which is the third or fourth lowest stomach pH among animal species.

"The pH is very low in in normal physiological pH, it could be 1.2, 1.3. That's a very, very acidic environment. In fact, humans have I think the third or the fourth lowest pH in the animal kingdom, only next to like vultures" (said at 0:49:06)

A systematic review compiling vertebrate gastric acidity data found that normal human baseline gastric pH is exceptionally acidic (typically measured around 1.2 to 1.5). In comparative analyses across mammal and bird taxa, human stomach acidity ranks among the most acidic vertebrates, clustering with obligate and facultative scavengers (such as vultures) rather than generalist primates or herbivores.

0:50:54overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

Microbiologist Raúl Cano isolated viable Bacillus endospores dating 25 to 40 million years old from ancient bees preserved in amber.

"His name is Raúl Cano. He did all of that work... him and his team did all the work where they found microbes in the guts of ancient fossilized honeybees that were fossilized in amber just like the mosquito in Jurassic Park, right? And he was able to isolate Bacillus endospores from them that were 50 million and as old as 250 million years old." (said at 0:50:54)

Raúl Cano and colleagues published the isolation and revival of viable Bacillus endospores (most closely related to Bacillus sphaericus) from the abdominal contents of extinct stingless bees preserved in 25- to 40-million-year-old Dominican amber (PMID: 7538699). However, the spoken claim exaggerates the age by asserting these bee-derived isolates were 'as old as 250 million years old.' Claims of viable 250-million-year-old bacteria come from separate studies of Permian salt crystals (halite), not amber-entombed bees. Furthermore, ancient DNA and spore revival claims from millions of years ago remain contentious in paleomicrobiology due to debates surrounding contamination and background radiation damage over geological timescales.

0:57:18overstatedlowGLP1s & Your Gut in Menopause: What Women Need to Know

Bitter taste receptors located throughout the digestive tract account for nearly 50% of all digestive signaling in the body.

"turning on of the bitter taste receptors throughout the digestive tract accounts for almost 50% of all of the digestive signaling. Right? So, think of them as switches going through this massive machine. Turning on these switches to effectuate the digestive process requires bitter taste receptors being activated by bitter compounds" (said at 0:57:18)

While bitter taste receptors (TAS2Rs / T2Rs) are expressed throughout the gastrointestinal mucosa and play documented roles in chemoreception, hormone secretion (such as GLP-1), gastric acid secretion, motility, and metabolic regulation, there is no scientific basis or quantification showing that they account for "nearly 50% of all digestive signaling." Gastrointestinal digestion and motility are coordinated by a complex, multi-layered system dominated by the enteric nervous system (ENS), autonomic nervous system input (vagus and sympathetic nerves), peptide hormones (gastrin, CCK, secretin, motilin, ghrelin, etc.), mechanical stretch receptors, and multiple non-bitter nutrient receptors (such as sweet/umami TAS1Rs, free fatty acid GPCRs, and amino acid transporters). Claiming a specific, precise figure of 50% for bitter taste receptors dramatically overstates their contribution relative to these primary neural and hormonal signaling networks.

0:58:37supportedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Activation of bitter taste receptors stimulates L cells to secrete GLP-1, CCK, GIP, and PYY, and activates AMPK.

"Aren't bitter taste receptors what signal the L cells of the gut to kick up, too? And that's what The L cells are what secrete GLP-1. GUEST1: That's exactly right, yeah... It kicks up, you know, CCK, GLP-1s, GIPs. It kicks up the PYY, yep. And AMPK as well" (said at 0:58:37)

Activation of bitter taste receptors (TAS2Rs/T2Rs) expressed on enteroendocrine cells in the gut stimulates the secretion of satiety and incretin hormones, including GLP-1, PYY, and CCK, and triggers downstream activation of AMP-activated protein kinase (AMPK) signaling. While classical histology attributes CCK primarily to I cells and GIP to K cells (whereas GLP-1 and PYY are secreted by L cells), colonic and intestinal enteroendocrine cells expressing bitter taste receptors colocalize with and secrete these peptides upon bitter agonist stimulation.

1:01:08supportedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Excessive accumulation of secondary bile salts, produced when gut microbes convert primary bile, can cause inflammation in the large intestine.

"there are microbes in your gut that'll convert that bile into what we call secondary bile salts. And those secondary bile salts can be very useful and helpful, but if you do too much of it, it can actually create inflammation in the large bowel." (said at 1:01:08)

The speaker's statement accurately reflects the physiology and pathophysiology of bile acid metabolism. Primary bile acids synthesized by the liver are metabolized by colonic bacteria into secondary bile acids (such as deoxycholic acid and lithocholic acid). While physiological concentrations contribute to homeostatic signaling, excessive levels or detergent activity can disrupt mucosal integrity, promote bacterial translocation, and trigger colonic epithelial inflammation.

1:01:12needs contextlowGLP1s & Your Gut in Menopause: What Women Need to Know

Screening of healthy, normal-BMI adults in their mid-20s showed that approximately 55% had elevated LPS levels indicative of profound leaky gut.

"when we did our leaky gut studies, we were doing it in people in their mid-20s who were by FDA standards healthy normals, right? So, they didn't have any conditions, they didn't have any issues, weren't on any drugs or management of any disease, and they were all a normal BMI and so on. But, about 55% of them had very profound leaky gut. Right? Very elevated levels of LPS." (said at 1:01:12)

The claim refers to a screening study conducted in healthy, normal-BMI young adults evaluating postprandial dietary endotoxemia (elevated lipopolysaccharide [LPS] levels, often framed as indicative of intestinal permeability or 'leaky gut'). In a trial by Campbell et al. (2017), healthy subjects were screened for postprandial dietary endotoxemia following a high-fat challenge meal, categorizing participants as 'responders' if their postprandial serum endotoxin increased significantly (at least 5-fold) over baseline. While elevated postprandial LPS levels were indeed found in a substantial subset of seemingly healthy, normal-weight individuals, framing transient postprandial endotoxemia after a high-fat meal challenge as 'profound leaky gut' requires context, as postprandial endotoxemia is a temporary physiological response to lipid absorption rather than definitive proof of chronic intestinal barrier breakdown.

1:04:45overstatedmoderateGLP1s & Your Gut in Menopause: What Women Need to Know

Bitter receptors control upwards of half of all digestive signals in the human body.

"what a bitter is, you know, and it controls upwards of half of all your digestive signals, which is amazing." (said at 1:04:45)

Extraoral bitter taste receptors (TAS2Rs) are expressed throughout the human gastrointestinal tract on enteroendocrine, Paneth, goblet, and tuft cells, where their activation influences gut motility, mucosal defence, and the secretion of digestive and satiety hormones like GLP-1 and CCK. However, there is no scientific basis for the claim that they control 'upwards of half' of all digestive signals. Gastrointestinal physiology relies on an extensive network of diverse inputs, including the enteric and autonomic nervous systems, mechanoreceptors, and numerous specialized chemosensory receptors for macronutrients (carbohydrates, amino acids, and fats via TAS1Rs, calcium-sensing receptors, and free fatty acid receptors), along with dozens of peptide hormones and neurotransmitters.

1:05:35supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

One of the primary biological functions of bitter taste perception in the mouth is to detect potential dietary poisons.

"one of the most important aspects of the bitters for the mouth is to detect potential poisons." (said at 1:05:35)

The scientific consensus in evolutionary biology and gustatory physiology establishes that bitter taste perception evolved primarily as a protective mechanism to detect and deter the ingestion of naturally occurring toxic substances, such as plant alkaloids and poisons.

1:05:50supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

The cephalic phase response increases salivation and gastric secretions to prepare the digestive system for incoming food.

"The cephalic response is just your brain getting ready for food, right? So, it starts increasing salivation. It starts increasing some gastric secretions. Gets your body ready for food coming in" (said at 1:05:50)

The cephalic phase response is an established physiological reflex mediated by the central and autonomic nervous systems (primarily via the vagus nerve) triggered by sensory cues such as the sight, smell, or taste of food. It stimulates salivation, gastric acid and enzyme secretion, and pancreatic secretions in anticipation of nutrient ingestion to prepare the gastrointestinal tract for digestion.

1:06:15supportedhighGLP1s & Your Gut in Menopause: What Women Need to Know

Smelling and seeing food triggers the cephalic phase response.

"you can actually increase the cephalic response just by smelling food and seeing food. And we all have done that, right? You smell bacon, for example, and you're like, "Ah." Your mouth starts watering, right? That's a cephalic response." (said at 1:06:15)

The claim is supported by established human physiological research. Cephalic phase responses—including anticipatory salivation, digestive enzyme secretion, and hormonal shifts—are rapid preabsorptive physiological reactions triggered by sensory cues such as the sight, smell, taste, and texture of food.

Fact-checked episodes

Publications